Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
NexImmune, Inc. - Common Stock
(NQ:
NEXI
)
3.930
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about NexImmune, Inc. - Common Stock
NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
February 06, 2024
From
NexImmune, Inc.
Via
GlobeNewswire
NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
February 02, 2024
From
NexImmune, Inc.
Via
GlobeNewswire
NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes
October 24, 2023
From
NexImmune, Inc.
Via
GlobeNewswire
NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting
October 19, 2023
From
NexImmune, Inc.
Via
GlobeNewswire
NexImmune Announces 1-for-25 Reverse Stock Split
October 18, 2023
From
NexImmune, Inc.
Via
GlobeNewswire
NexImmune Announces Workforce Reduction to Enable Continued AIMTM Nanoparticle Platform Development Strategy
August 31, 2023
From
NexImmune, Inc.
Via
GlobeNewswire
NexImmune Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 10, 2023
From
NexImmune, Inc.
Via
GlobeNewswire
NexImmune Reports First Quarter 2023 Financial Results and Provides Business Updates
May 15, 2023
From
NexImmune, Inc.
Via
GlobeNewswire
Selexis and NexImmune Sign Service Agreement to Advance Multiple Immunotherapies Targeting Rare Cancers and Autoimmune Disorders
September 08, 2022
From
Selexis SA and NexImmune Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.